Myriad Genetics reported $30.6M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Agilent USD 1.12B 28M Jun/2026
Becton, Dickinson and Co. USD 3.19B 125M Sep/2026
Bio-Rad Laboratories USD 783.9M 3.3M Sep/2026
Bruker USD 1.12B 1.4M Jun/2026
Danaher USD 3.13B 126M Sep/2026
Illumina USD 667M 38M Sep/2026
J&J USD 15.38B 233M Sep/2026
Mettler Toledo International USD 439.66M 28.1M Sep/2026
Myriad Genetics USD 30.6M 2.7M Jun/2026
OraSure Technologies USD 30.07M 236K Jun/2026
Pacific Biosciences Of California USD 60.28M 806K Sep/2026
Quest Diagnostics USD 218M 15M Sep/2026
Quidel USD 642.7M 23.8M Sep/2026
Repligen USD 182.2M 4.4M Sep/2026
Revvity USD 388.85M 10.35M Sep/2026
Standard Biotools USD 17.62M 514K Sep/2026
Thermo Fisher Scientific USD 5.64B 16M Sep/2026
Veracyte USD 25.82M 3.16M Sep/2026
Waters USD 1.32B 53M Sep/2026